期刊
FUTURE NEUROLOGY
卷 6, 期 5, 页码 587-609出版社
FUTURE MEDICINE LTD
DOI: 10.2217/FNL.11.42
关键词
cerebral amyloid angiopathy; cerebral microbleed; cerebral small-vessel disease; gradient-recalled echo; hypertensive vasculopathy; microhemorrhage; vascul cognitive impairment
资金
- Greek State Scholarship Foundation
- Department of Health/Higher Education Funding Council for England
- Stroke Association
- Department of Health's NIHR Comprehensive Biomedical Research Centres
In the last decade or so, cerebral microbleeds (CMBs) - tiny perivascular hemorrhages seen as small, well-demarcated, hypointense, rounded lesions on MRI sequences that are sensitive to magnetic susceptibility - have generated increasing interest among neurologists and clinical stroke researchers. As MRI techniques become more sophisticated, CMBs are increasingly detected in various patient populations (including all types of stroke, Alzheimer's disease and vascular cognitive impairment) and healthy community-dwelling older people. Their presence rai ses many clinical dilemmas and intriguing pathophysiological questions. CMBs are emerging as an important new manifestation and diagnostic marker of cerebral small-vessel disease. They are a potential predictor of future intracerebral hemorrhage risk, a possible contributor to cognitive impairment and dementia and a potential key link between vascular and degenerative pathologies. In this article, we discuss the available pathological, neuroimaging and clinical studies in the field, and we provide a modern overview of the clinical and pathophysiological implications of CMBs in different disease settings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据